Uncategorized

Resolved: The illegal use of drugs ought to be treated as a matter of public health, not of criminal justice.

General Drug use disorders: Impact of a public health rather than a criminal justice approach (2017) Framing drug and alchohol abuse as a public health problem (2018) Drug use: Public health issue or criminal justice matter? (2013) Framing drug and alchohol abuse as a public health problem in Britain (2018) Pro Rethinking America’s “War on Drugs” as a Public Health problem (2001) Drug use must be treated as a public

Spring 2018 Promotions

Online Coaching/Training Get access to the best online training and support! Public Forum, LD, and Policy PF Training! Georgetown International Public Forum Tournament Georgetown Public Forum Workshop Join us this summer from June 24-July 3rd for the Georgetown Public Forum workshops in Washington, DC!          

Main Arguments — Arms Sales Topic

Pro Arms sales bad for various humanitarian reasons, including war in Yemen violates humanitarian principles.  General ethics advantage. Arms sales to Saudi Arabia support its war in Yemen, other reasons the war in Yemen is bad Russian arms sales good for their economy (it’s good if Russia fills in if we leave) China influence good, China will fill in if we leave Should take a moral stand/”shun” Saudi Arabia because

Resolved: The United States should end its arms sales to Saudi Arabia (Bibliography Plus File)

Resolved: The United States should end its arms sales to Saudi Arabia (Bibliography Plus File)

Background Saudi Arabia: Background and US Relations (September, 2018) Trump touts Saudi Arms Sales (March 2018) Arms Sales in the Middle East: Trends and Analytical Perspectives on US Policy  (2017) How much does Saudi Arabia spend on arms deals with the US? (November 2018) US-Saudi Cooperation: Conditioning Arms Sales to Build Trust (November 2018) Europeans cut Saudi arms sales (March 2018) Arms Sales to Saudi Arabia: Worth the Cost?  Saudis

Resolved: The United States federal government should prioritize reducing the federal debt over promoting economic growth.

Resolved: The United States federal government should prioritize reducing the federal debt over promoting economic growth.

Resolved: The United States federal government should prioritize reducing the federal debt over promoting economic growth. Introduction The January Public Forum resolution presents a quandary because the issue the resolution aims to answer – should the federal government spend money to limit its total federal debt or should it spend money to stimulate the economy – is not in any way obvious to anyone who reads this resolution, because that’s

The Value of PF Debate Relative to Other Debate Events

The Value of PF Debate Relative to Other Debate Events

Stefan Bauschard Introduction In the Fall of 2015 I started a Public Forum debate team for the Lakeland school district. Prior to that, I spent 30 years as a Policy debater and a Policy debate coach. Since then I have largely been coaching Public Forum debate, though I still judge at some college Policy tournaments and coach Policy debate online. Why did I do it? Because I simply had a

Resolved: The United States federal government should impose price controls on the pharmaceutical industry

Background A price ceiling is a legal maximum (2017) The true story of America’s sky high prescription drug prices. (2018) Trump is, in effect, taking on high drug prices (2018) Trump caves to industry on price controls (2017) The effect of price controls on pharmaceutical research. ( 2003).cutting prices by 40 to 50 percent in the United States will lead to between 30 and 60 percent fewer R and D projects being undertaken in the early stage of developing a new drug. Relatively modest price changes, such as 5 or 10 percent, are estimated to have relatively little impact on the incentives for product development – perhaps a negative 5 percent.” Cost Control: Examining drug price controls around the world. (2018) This examines the impact of high drug prices and price controls in 5 different countries Should the government do more to regulate drug prices? (2018).   (T) there is a long-running debate in Washington, D.C., and in state capitols across the country, about whether governments should directly intervene to regulate or set prices for drugs.  The following conversation simulates this debate and provides the facts you need to know. Room for Debate: Should the government impose price controls on pharmaceuticals? 27 things the fed can do to cut drug prices (2017) Pro Prescription drug prices: Why the US is an outlier (2017). Various factors contribute to high per capita drug spending in the U.S. While drug utilization appears to be similar in the U.S. and the nine other countries considered, the prices at which drugs are sold in the U.S. are substantially higher. These price differences appear to at least partly explain current and historical disparities in spending on pharmaceutical drugs. U.S. consumers face particularly high out-of-pocket costs, both because the U.S. has a large uninsured population and because cost-sharing requirements for those with coverage are more burdensome than in other countries. Most Americans support reducing pharmaceutical costs. International experience demonstrates that policies like universal health coverage, insurance benefit design that restricts out-of-pocket spending, and certain price control strategies, like centralized price negotiations, can be effective. Curbing unfair drug prices (2017) Other countries can lower drug prices — we can (2017) The way to fix high drug prices is to do what other countries do (2018) Americans pay too much of global drug research costs (2018) Expensive drugs a drag on consumers and the economy (2017) Addressing out of control prescription drug prices (2018) Soaring drug prices: Here’s how to control them  States and the Rising Cost of Pharmaceuticals: A Call to Action (2016) Value in Pharmaceutical Pricing: A Case Study in Canada Con A prescription for disaster (2018).  Competition and market forces, not price controls, will drive down drug costs and will do so better than any heavy-handed legislation or regulation.  In early 2014, reactions to drug prices reached a fever pitch after Gilead announced its $84,000 list price tag for a 12-week course of the hepatitis C drug Sovaldi and reached a crescendo when Turing Pharmaceuticals, led by former hedge fund manager